NILANDRON(Nilutamide) is an antiandrogen used to treat prostate cancer. NILANDRON(Nilutamide) is a pure, nonsteroidal anti-androgen which blocks androgen binding to androgen receptors. NILANDRON(Nilutamide) blocks the action of androgens of adrenal and testicular origin. NILANDRON(Nilutamide) is contraindicated in patients with known hypersensitivity to the drug or to any constituents of the drug product and in patients with severe hepatic dysfunction or with severe respiratory insufficiency. NILANDRON(Nilutamide) is also contraindicated in women and children. Patients administered nilutamide should be warned against consuming alcohol because of a possible disulfiramlike reaction. Patients should be advised regarding impairment of light adaptation if they plan to operate a vehicle or machinery.
Refer to NILANDRON(Nilutamide) dosing protocol by which patient is being treated. Adults: Oral: 300 mg, usually 300mg daily for the first 30 days, then 150mg once daily (with or without food) Dosage in myelosuppression: no adjustment required Dosage in renal failure: no adjustment required Dosage in hepatic failure: if transaminase >2-3x upper limit of normal, interrupt treatment.
Nilandron Side Effects
NILANDRON(Nilutamide) side effects include Dizziness (3%, Hot flushes (14%), Gynecomastia (< 1%), Gastrointestinal Nausea and vomiting (4%), Constipation, Anorexia (1%), Hematologic Anemia (4%), Elevated liver function tests (4%), Hepatitis (<1%),Photophobia (1%), Retarded light-to-dark adaptation (11%), Visual disturbances (27%), Dyspnea, Interstitial pneumonitis (rare), Fatigue, Alcohol intolerance, Hyperglycemia, Asthenia. Retarded light-to-dark adaptation usually improves on treatment, and usually resolves when treatment is discontinued. Patients should be cautioned about driving at night or through tunnels. This effect can be alleviated by the wearing of tinted glasses. Interstitial pneumonitis has been described, with an apparently higher incidence in patients of Asian origin. Treatment of NILANDRON(Nilutamide) should be discontinued if pneumonitis is diagnosed, and the use of steroids should be considered. Patients of Asian origin may also be at a high risk of liver function test abnormalities.
The content on this page has been supplied to canadianpharmacyking by an independent third party contracted to provide information for our website.
canadianpharmacyking relies on these third parties to create and maintain this information and cannot guarantee the medical efficacy, accuracy or reliability of the information that has been provided to us.
If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a health professional.
Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy.
We affiliate with other dispensaries that ship product to our customers from the following jurisdictions: Canada, Singapore, New Zealand, Turkey, Mauritius, and United Kingdom.
The items in your order maybe shipped from any of the above jurisdictions.
The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with our authorized dispensaries that procure product through reliable sources.